jam-c and reverse transendothelial migration of

8
September 2015 NIAA John Snow Anaesthesia Intercalated BSc Awards 2014 Final Report ___________________________________________________________________________ 1 JAM-C and reverse transendothelial migration of neutrophils under conditions of sepsis Gregor Devoy (Supervised by Prof Helen Galley) Academic Unit of Anaesthesia and Intensive Care, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK ___________________________________________________________________________ Abbreviations HUVECs = human umbilical vein endothelial cells JAM-C = junctional adhesion molecule C PepG = peptidoglycan LPS = lipopolysaccharide ROS = reactive oxygen species LTB4 = leukotriene B4 rTEM = reverse transendothelial migration mAb = monoclonal antibody TEM = transendothelial migration Background Sepsis is a dysregulated inflammatory response to infection and remains a major cause of mortality in the UK with around 37,000 deaths each year. 1 Neutrophils are the first leucocytes to arrive at sites of infection or tissue damage and exit the blood circulation via a tightly controlled process called transendothelial migration (TEM). 2 On arrival, neutrophils release cytokines and chemokines for the recruitment of additional leucocytes however, prolonged neutrophil activation can result in damage to the host. 3 In sepsis, both neutrophil elastase and leukotriene B4 (LTB4) are reported to be upregulated. 4 Recent studies suggest that neutrophils can undergo reverse TEM (rTEM) thereby returning to the circulation. Junctional adhesion molecule C (JAM-C) was reported to be a key regulator of rTEM such that pharmacological blocking of JAM-C increased rTEM. 5, 6 Both LTB4 and elastase may have roles in rTEM, and work in mice suggests that neutrophil elastase regulates JAM-C expression. 7 Interestingly, reactive oxygen species (ROS) are also reported to affect JAM-C expression and oxidative stress is a hallmark of sepsis. 5 Remote organ injury commonly occurs in patients with sepsis and is associated with neutrophil infiltration. The role of rTEM in sepsis remains unknown but may explain why neutrophils are found in remote tissues where they can cause subsequent damage. This in vitro laboratory pilot study aimed to investigate rTEM under conditions mimicking sepsis and determine the effects of JAM-C, elastase and LTB4 inhibition. Additionally, the effect of melatonin, a potent anti-oxidant, was also investigated.

Upload: others

Post on 02-Oct-2021

12 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: JAM-C and reverse transendothelial migration of

September 2015

NIAA John Snow Anaesthesia Intercalated BSc Awards 2014

Final Report

___________________________________________________________________________

1

JAM-C and reverse transendothelial migration of neutrophils under

conditions of sepsis

Gregor Devoy

(Supervised by Prof Helen Galley)

Academic Unit of Anaesthesia and Intensive Care, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK

___________________________________________________________________________

Abbreviations HUVECs = human umbilical vein endothelial cells

JAM-C = junctional adhesion molecule C PepG = peptidoglycan

LPS = lipopolysaccharide ROS = reactive oxygen species

LTB4 = leukotriene B4 rTEM = reverse transendothelial migration

mAb = monoclonal antibody TEM = transendothelial migration

Background

Sepsis is a dysregulated inflammatory response to infection and remains a major cause of

mortality in the UK with around 37,000 deaths each year.1

Neutrophils are the first leucocytes to arrive at sites of infection or tissue damage and exit

the blood circulation via a tightly controlled process called transendothelial migration

(TEM).2 On arrival, neutrophils release cytokines and chemokines for the recruitment of

additional leucocytes however, prolonged neutrophil activation can result in damage to the

host.3 In sepsis, both neutrophil elastase and leukotriene B4 (LTB4) are reported to be

upregulated.4

Recent studies suggest that neutrophils can undergo reverse TEM (rTEM) thereby returning

to the circulation. Junctional adhesion molecule C (JAM-C) was reported to be a key

regulator of rTEM such that pharmacological blocking of JAM-C increased rTEM.5, 6

Both

LTB4 and elastase may have roles in rTEM, and work in mice suggests that neutrophil

elastase regulates JAM-C expression.7 Interestingly, reactive oxygen species (ROS) are also

reported to affect JAM-C expression and oxidative stress is a hallmark of sepsis.5

Remote organ injury commonly occurs in patients with sepsis and is associated with

neutrophil infiltration. The role of rTEM in sepsis remains unknown but may explain why

neutrophils are found in remote tissues where they can cause subsequent damage.

This in vitro laboratory pilot study aimed to investigate rTEM under conditions mimicking

sepsis and determine the effects of JAM-C, elastase and LTB4 inhibition. Additionally, the

effect of melatonin, a potent anti-oxidant, was also investigated.

Page 2: JAM-C and reverse transendothelial migration of

September 2015

NIAA John Snow Anaesthesia Intercalated BSc Awards 2014

Final Report

___________________________________________________________________________

2

Methods

Human umbilical vein endothelial cells (HUVECs) were cultured with lipopolysaccharide

(LPS) and peptidoglycan (PepG) for 24 hours to mimic sepsis. Endothelial cell monolayers

were co-treated with a JAM-C monoclonal antibody (mAb), elastase inhibitor, an LTB4

receptor antagonist or various doses of melatonin. The LTB4 receptor antagonist was added

either as a pre-treatment before the neutrophils or as a post-treatment at the same time as

the neutrophils. All other treatments were added before and after the neutrophils to

provide treatment throughout.

Following approval by the University of Aberdeen College of Life Sciences and Medicine

Ethics Review Board and written informed consent, whole blood was collected from healthy

volunteers of both sexes and neutrophils were isolated by density centrifugation.

Neutrophils were fluorescently labelled before being added to endothelial cell monolayers.

After 1h, neutrophils which migrated remained between the endothelial cells while

neutrophils which did not migrate were removed by thorough washing. After a further 24

hours, reverse migrated neutrophils returning to the apical surface were removed, lysed and

quantified by measuring fluorescence (Figure 1). The proportions of neutrophils at each

stage in the experiment could be calculated by measuring fluorescence (Figure 2).

High resolution light microscopy was performed to examine the neutrophils and endothelial

cells in co-culture. Immunofluorescence was performed to determine JAM-C expression in

the presence and absence of the JAM-C mAb.

Add fluorescently

labelled neutrophils

Incubate for 1 hour

Wash to remove

non-migrated neutrophils

Add fresh medium and

incubate for 24 hours

Collect rTEM neutrophils

→→ →→

→→ →→

→→ →→

→→ →→

Figure 1: Summary of in vitro model. The cross-section of a well is outlined with endothelial cells cultured on

bottom. Green stars indicate fluorescently labelled neutrophils. Following 1 hour incubation, a proportion of

neutrophils undergo TEM. Non-migrated neutrophils are removed then medium replaced. After 24 hours

reverse migrated neutrophils return to the apical endothelial cell surface from which they are collected and

quantified by measuring fluorescence. Abbreviations: TEM, transendothelial migration; rTEM, reverse TEM.

Page 3: JAM-C and reverse transendothelial migration of

September 2015

NIAA John Snow Anaesthesia Intercalated BSc Awards 2014

Final Report

___________________________________________________________________________

3

Results

Initial cell viability acid phosphatase assays were performed (data not shown) using a range

of doses of each treatment. Doses were selected based on manufacturer recommendations

and the current literature. When cells were treated with the JAM-C mAb (0.2μg/ml and

2μg/ml) no effect on cell viability was observed compared to vehicle controls (P ≥ 0.05).

Likewise, cell viability was similar compared to vehicle controls when cells were treated with

the LTB4 receptor antagonist (10nM, 100nM and 500nM). However, a dose-dependent

effect was observed when cells were treated with the elastase inhibitor and cell viability was

significantly lower (P < 0.01) at the 1mM dose. At the 0.01mM and 0.1mM dose, cell viability

was no different than without the elastase inhibitor (P ≥ 0.05). Melatonin was not studied

since previous work by the University of Aberdeen Anaesthesia and Intensive Care Research

Group reported no effect of melatonin on cell viability at doses between 0.1μM and

500μM.8

Following analysis of preliminary reverse migration experiments using the same range of

doses of each treatment as cell viability assays (data not shown), a final model was

established. In the final model, each experiment used neutrophils isolated from a different

volunteer (n=14) (Table 1).

High resolution light microscopy suggested neutrophils were adherent to the outer

membrane of HUVECs, especially at cell junctions (Figure 3).

TEM after 1 hour

F0

F2

F3

F1

Figure 2: Cross-section of a well illustrating neutrophil fractions. Fraction 0 (F0) was quantified by measuring

fluorescence of the neutrophils originally added. All other fractions were calculated as a proportion of F0.

Fraction 1 (F1) denotes the proportion of neutrophils removed following the wash step while Fraction 2 (F2)

denotes the proportion of reverse migrated neutrophils. Fraction 3 (F3) is the proportion of neutrophils

remaining between the endothelial cells at the completion of the experiment. The proportion of neutrophils

undergoing TEM after 1 hour = F0 – F1. Note in experimental conditions the endothelial cells are directly

cultured on the bottom of the well. Abbreviations: TEM, transendothelial migration.

Page 4: JAM-C and reverse transendothelial migration of

September 2015

NIAA John Snow Anaesthesia Intercalated BSc Awards 2014

Final Report

___________________________________________________________________________

4

The proportion of neutrophils at each stage of the experiment for cells treated with LPS and

PepG only is outlined in Figure 3. The proportion of neutrophils migrating within the first

hour ranged from 50% to 85% with a median value of 67%. The proportion of neutrophils

which reverse migrated ranged from 16% to 62% with a median of 46% (Figure 4).

Reverse migration was compared between each treatment by calculating the percentage

change relative to reverse migration in cells treated with LPS and PepG alone (Figure 4).

When cells were treated with the JAM-C mAb, a statistically significantly higher proportion

of neutrophils reverse migrated compared to cells treated with LPS/PepG alone (P=0.006).

However, the proportion of neutrophils which reverse migrated was similar for cells treated

with the elastase inhibitor, LTB4 receptor antagonist and melatonin compared to cells

treated with LPS/PepG alone (Figure 5).

Although quantitative analysis of immunofluorescence was not possible, the addition of the

JAM-C mAb appears to result in less JAM-C expression compared to cells treated with LPS

and PepG alone (Figure 6).

Table 1: Final in vitro model volunteer characteristics

Characteristics

Volunteers

n=14

Sex (male:female) 11:3

Age (median [range]) 27 [21-62]

100 µm

Figure 3: High-resolution light microscopy of HUVECs treated with LPS and PepG in co-culture with neutrophils.

Green outline: HUVEC outer membrane. Orange outline: neutrophil (≈ 12 to 17 µm). White arrow: neutrophil

bound to the junction between HUVECs. No staining. Magnification 40x.

Page 5: JAM-C and reverse transendothelial migration of

September 2015

NIAA John Snow Anaesthesia Intercalated BSc Awards 2014

Final Report

___________________________________________________________________________

5

Figure 5: Reverse transendothelial migration of human neutrophils treated with LPS/PepG plus either anti-

JAM-C mAb ([clone 208206], R&D Systems, Abingdon, UK; 2μg/ml), the elastase inhibitor (Sigma, Dorset, UK;

1mM), the LTB4 receptor antagonist ([LY223982], Cayman Chemical, Michigan, USA; 100nM) added either

before or after addition of neutrophils, or various doses of melatonin (Sigma, Dorset, UK). Results are

expressed as % of rTEM in the presence of LPS/PepG alone (for LPS/PepG only the % change is based on the

baseline median value). Box and whisker plots show median, interquartile and full range. Data compared using

Friedman/Wilcoxon test for paired data (n = 14). The final concentrations of LPS and PepG were 2.5mg/ml and

25mg/ml respectively.

Figure 4: Reverse migration fractions LPS + PepG + vehicle control. Fractions are labelled on the x-axis. Each

experiment used neutrophils isolated from a different volunteer (n = 14). Box and whisker plots show median,

interquartile and full range of data. Fractions were calculated as a proportion of the total neutrophils initially

added to each well (F0). No statistical analysis.

F0 F1

TEM a

fter 1

hou

rF2 F3

0

50

100

150LPS + PepG + vehicle control µ

Per

cent

age

of n

eutr

ophi

ls (

%)

0

50

100

150

200 P = 0.006

+ Melatonin

0 .5 1.0 5.0

% c

ha

ng

e

Page 6: JAM-C and reverse transendothelial migration of

September 2015

NIAA John Snow Anaesthesia Intercalated BSc Awards 2014

Final Report

___________________________________________________________________________

6

Discussion

In this study, reverse transendothelial cell migration of human neutrophils from healthy

volunteers under conditions mimicking sepsis was studied. In addition the effects of

inhibiting JAM-C, elastase or LTB4, and the effect of melatonin were investigated. We found

that around two thirds of neutrophils migrated into the endothelial cell layer and of these

around 70% reverse migrated back. We also found that inhibition of JAM-C using a blocking

mAb increased reverse migration but inhibition of elastase or LTB4 had no effect. Treatment

with melatonin also did not affect reverse migration.

We found that under conditions mimicking sepsis, the proportion of neutrophils migrating

within the first hour (median 67%) was consistent with previous static transmigration

models where the percentage was reported to be around 60% when neutrophils were

treated with TNF-α.9

We also found that a statistically significantly higher proportion of neutrophils reverse

migrated from the endothelial monolayer in HUVECs treated with a JAM-C mAb under

conditions of sepsis compared to LPS and PepG alone.

HUVECs treated with LPS + PepG + vehicle control:

A B

C D

100 µm

HUVECs treated with LPS + PepG + JAM-C mAb:

A B

C D

100 µm

Figure 6: Immunofluorescence JAM-C expression. A, CD31 fluorophore conjugated antibody (red) indicating

HUVEC outer membrane; B, JAM-C fluorophore conjugated mAb (green) showing JAM-C expression; C, DAPI

stain (blue) indicating the location of the nucleus; D, Combined image of A, B and C. JAM-C expression appears

lower in cells treated with JAM-C mAb (right image) compared to vehicle control (left image). Magnification

40x.

Page 7: JAM-C and reverse transendothelial migration of

September 2015

NIAA John Snow Anaesthesia Intercalated BSc Awards 2014

Final Report

___________________________________________________________________________

7

This finding is supported by immunofluorescent imaging of JAM-C expression. Altogether,

these findings concur with previous work investigating JAM-C inhibition in ischaemia-

reperfusion injury in a mouse model which, although differs in aetiology compared to sepsis,

both result in oxidative stress and remote organ injury.5

Although it had been suggested that elastase and/or LTB4 have a role in regulation of JAM-C

and therefore reverse migration we found no difference when cells were co-treated with

antagonists of these mediators along with LPS/PepG.

Melatonin is well-known for its role in sleep regulation but it is also a potent antioxidant,

with marked anti-inflammatory effects.8, 10

We hypothesised that given the role of oxidative

stress in sepsis and ischaemia reperfusion, and the importance of oxidative stress in terms

of neutrophil and endothelial cell activation melatonin may have some effects on migration

of neutrophils. However, we found no effect of melatonin in our study.

Although, there was variable responses of each treatment between individual subjects,

expression of results as percentage change from baseline values with LPS/PepG alone failed

to demonstrate any effects of treatments other than JAM-C inhibition. This may represent

inadequate power of the study. In this pilot study we recruited 14 volunteers in the time

available.

Conclusion

In this study, a model and methods for investigating reverse migration of neutrophils under

conditions mimicking sepsis was successfully established. We found that neutrophils did

undergo reverse migration and that inhibition of JAM-C increased this, under conditions

mimicking sepsis. This confirmed the role of JAM-C in the process of reverse migration.

Acknowledgements

The study was funded by a John Snow Intercalated BSc award from the British Journal of

Anaesthesia. I would like to convey my huge appreciation for this funding and the

opportunity to undertake this project. I would also like to thank my supervisor, Professor

Galley, for her excellent support and guidance.

I was awarded a First Class degree and the results will be submitted for presentation at the

Anaesthetic Research Society meeting in York in November 2015.

Page 8: JAM-C and reverse transendothelial migration of

September 2015

NIAA John Snow Anaesthesia Intercalated BSc Awards 2014

Final Report

___________________________________________________________________________

8

References

1. Daniels R. Surviving the first hours in sepsis: getting the basics right (an intensivist's

perspective). Journal of Antimicrobial Chemotherapy. 2011;66(Supplement 2):ii11-ii23.

2. Ley K, Laudanna C, Cybulsky M, Nourshargh S. Getting to the site of inflammation: the

leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678-689.

3. Seeley E, Matthay M, Wolters P. Inflection points in sepsis biology: from local defence to

systemic organ injury. AJP: Lung Cellular and Molecular Physiology. 2012;303(5):L355-

L363.

4. Schlag G, Redl H. Pathophysiology of Shock, Sepsis and Organ Failure. Berlin: Springer

Science; 2011.

5. Woodfin A, Voisin M, Beyrau M, Colom B, Caille D, Diapouli F et al. The junctional

adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils

in vivo. Nature Immunology. 2011;12(8):761-769.

6. Bradfield P, Scheiermann C, Nourshargh S, Ody C, Luscinskas F, Rainger G et al. JAM-C

regulates unidirectional monocyte transendothelial migration in inflammation. Blood.

2007;110(7):2545-2555.

7. Colom B, Bodkin J, Leinster A, Aurrand-Lions M, Chavakis T, Imhof B et al. Local cleavage

of endothelial cell junctional adhesion molecule (JAM)-C by neutrophil elastase governs

development of systemic inflammation. [Internet]. Birmingham, UK: Proceedings of The

Physiological Society; 2015 [cited 4 April 2015]. Available from:

http://www.physoc.org/proceedings/abstract/Proc%2037th%20IUPSPCB411

8. Lowes D, Almawash A, Webster N, Reid V, Galley H. Melatonin and structurally similar

compounds have differing effects on inflammation and mitochondrial function in

endothelial cells under conditions mimicking sepsis. British Journal of Anaesthesia.

2011;107(2):193-201.

9. Buckley C, Ross E, McGettrick H, Osborne C, Haworth O, Schmutz C et al. Identification of

a phenotypically and functionally distinct population of long-lived neutrophils in a model

of reverse endothelial migration. Journal of Leukocyte Biology. 2006;79:303-311.

10. Galley H. Oxidative stress and mitochondrial dysfunction in sepsis. British Journal of

Anaesthesia. 2011;107(1):57-64.